Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Crano-cure
- Development stage
- Phase 2
- Lead developer
- The Islamia University of Bahawalpur
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Crano-cure is a polyherbal formulation developed by researchers at the Islamia University of Bahawalpur, Pakistan, specifically for the treatment of acute uncomplicated urinary tract infections (UTIs). The formulation is composed of aqueous-ethanolic extracts from five medicinal plants: *Tribulus terrestris* (Gokhro), *Vaccinium macrocarpon* (cranberry), *Cuminum cyminum* (Zeera sufaid), *Rheum emodi* (Revand chini), and *Piper cubeba* (Kabab chini). Administered as 500 mg oral capsules twice daily, Crano-cure exhibits broad-spectrum antibacterial activity against common uropathogens such as *Escherichia coli*, *Klebsiella pneumoniae*, *Staphylococcus saprophyticus*, and *Proteus mirabilis*. In addition to its antimicrobial properties, the formulation provides antioxidant and antiseptic effects. Clinical evidence from a randomized trial suggests it serves as a safe and cost-effective alternative to standard antibiotic therapies like ciprofloxacin.
- Brand names
- Crano-cure
Beyond the preview
Go deeper on Crano-cure.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Crano-cure.